“Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine tumor of the skin with an estimated disease-associated mortality of 15–33%. Australia has a higher incidence of MCC compared to the rest of the world, thought to be due to a higher ultraviolet index.”
In this article published recently in the Asia Pacific Journal of Clinical Oncology, leading Australian experts present the latest in treatments and diagnosis of this often aggressive neuroendocrine skin cancer.
Well done to all involved including authors David L. Kok, Annie Wang, Wen Xu, Margaret S. T. Chua, Alexander Guminski, Michael Veness, Julie Howle, Richard Tothill, Ganessan Kichendasse, Michael Poulsen, Shahneen Sandhu, Gerald Fogarty – Peter MacCallum
To read more click below
